19. November 2009 06:56
We often hear about the perils of high blood pressure, but many Canadians are unaware that high blood pressure in the lungs - known as pulmonary hypertension (PH) - can also have fatal consequences. This month, the Pulmonary Hypertension Association of Canada hopes to raise awareness about PH - a rare but serious disease that can strike at any time and has no regard for race, age or gender.
[More]
16. November 2009 08:29
Yorkshire myeloma patients are set to be among the first to benefit from an innovative Myeloma Clinical Trial Network launched by Myeloma UK.
[More]
12. November 2009 03:18
Thousands of Neuromyelitis Optica (NMO) patients are potentially being misdiagnosed with Multiple Sclerosis (MS), according to Mayo Clinic Neurologist Sean Pittock, M.D., largely due to lack of awareness of NMO within the medical community.
[More]
c078d418-9574-4724-9186-13a8c7d344c0|0|.0
Posted in: Medical Condition News | Healthcare News
Tags: Antibody, Biochemistry, Biomarker, Brain, Education, Multiple Sclerosis, Nausea, Nervous System, Neurological Disease, Paralysis, Rare Disease, Vomiting
11. November 2009 05:55
Reportlinker.com announces that a new market research report is available in its catalogue: Pharmaceutical Pricing, Reimbursement and Parallel Trade 2006
[More]
92b9073c-d208-4dc1-b917-637eba109875|0|.0
Posted in: Pharmaceutical News
Tags: Antiretroviral, Aricept, Biotechnology, Bird Flu, Genetics, HIV/AIDS, Investment, Medicaid, Medicare, Pfizer, Pharmacogenomics, Rare Disease
6. November 2009 23:48
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today the latest recipient of the End Duchenne Grant Award Program.
[More]
6. November 2009 01:56
Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.
[More]
304215af-4ddf-4196-b671-35f1a9c2b302|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Apoptosis, Bone, Bone Marrow, Cancer, Chemotherapy, DNA, Leukemia, Lymphoma, Myeloid Leukemia, Oncology, Ovarian Cancer, Rare Disease, Voreloxin
4. November 2009 03:48
Canadian patients have less access to the latest medicines when compared to the world's developed countries, concludes a comprehensive new report released today. The Report shows Canada ranks 20th out of 25 OECD countries in public reimbursement of new drug therapies. Canada's grade of 56% is comparable with Iceland, Slovakia and Turkey.
[More]
28. October 2009 11:55
The Child Neurology Foundation (CNF) today announced that $30,000 was raised during Infantile Spasms Awareness Week (October 11-17) that will go towards researching the cause and treatment of this ultra-rare form of epilepsy.
[More]
23. October 2009 07:11
A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.
[More]
20. October 2009 05:52
The National Comprehensive Cancer Network (NCCN) recently made updates to the NCCN Clinical Practice Guidelines in Oncology(TM) for Acute Myeloid Leukemia, a cancer that starts inside the bone marrow and the most common acute leukemia affecting adults.
[More]
a33e3b56-c3a9-43fe-921e-180fea3a460a|0|.0
Posted in: Medical Condition News
Tags: Anthracycline, Bone, Bone Marrow, Cancer, Cell, Chemotherapy, Hospital, Leukemia, Myeloid Leukemia, Oncology, Rare Disease, Stem Cell, Transplant
15. October 2009 08:07
The Myelodysplastic Syndromes (MDS) Foundation says a wide range of international cooperation has been secured to help 18-year-old Wes Laporte of Ontario get treatment for a life-threatening condition in the US.
[More]
14. October 2009 07:03
The University of North Carolina at Chapel Hill has been awarded a five-year, $6.2 million renewal grant to continue its work as part of the National Institutes of Health's Rare Diseases Clinical Research Network (RDCRN).
[More]
12. October 2009 10:55
The Child Neurology Foundation (CNF) today announced the launch of a new educational website centered on infantile spasms (IS). The website, www.infantilespasmsinfo.org, is an educational resource developed by the CNF as one of the key components of Infantile Spasms Awareness Week.
[More]
8. October 2009 03:39
The antidote for acute liver failure caused by acetaminophen poisoning also can treat acute liver failure due to most other causes if given before severe injury occurs, UT Southwestern Medical Center researchers and their colleagues at 21 other institutions have found.
[More]
7. October 2009 03:05
The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.
[More]
6457013e-d4c7-4d02-aced-a5e7c8412dc7|0|.0
Posted in: Disease/Infection News
Tags: Allergy, Arthritis, Bone, Brain, Cancer, Cell, Churg-Strauss Syndrome, Cystic Fibrosis, Diabetes, Dopamine, Dystonia, Fibrosis, Health and Human Services, Immune Deficiency, Leigh Syndrome, Leukodystrophy, Mucolipidosis, Muscular Dystrophy, Nervous System, Neuropathy, Niemann-Pick Disease, Pompe Disease, Porphyria, Porphyrias, Prader-Willi Syndrome, Rare Disease, Retinitis Pigmentosa, Rett Syndrome, Spasmodic Dysphonia, Stem Cell, Stroke, Vasculitis, Wegener's Granulomatosis, Wiskott-Aldrich Syndrome
Subscribe